GeneDx Corp.
WGS | NASDAQ
$89.90
-$7.93 (-8.11%)
Sep 22, 2026, 11:25 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 427.54M | 305.45M | 202.57M | 234.69M | 212.2M | 179.32M |
Cost of Revenue | 129.37M | 111.05M | 112.56M | 261.44M | 228.8M | 175.3M |
Gross Profit | 298.17M | 194.4M | 90.01M | -26.75M | -16.6M | 4.03M |
Operating Income | -11.8M | -23.21M | -180.6M | -667.65M | -446.15M | -241.99M |
Interest Income | n/a | n/a | 1.11M | 2.54M | 79K | 506K |
Pretax Income | -21.14M | -52.63M | -176.69M | -598.03M | -245.39M | -241.34M |
Net Income | -21.02M | -52.29M | -175.77M | -548.98M | -245.39M | -241.34M |
Selling & General & Admin | 239.22M | 168.48M | 194.71M | 338.24M | 318.73M | 163.93M |
Research & Development | 72.03M | 45.72M | 58.27M | 86.2M | 105.16M | 72.7M |
Other Expenses | n/a | 3.41M | 17.63M | 216.46M | 5.66M | 9.4M |
Operating Expenses | 311.25M | 217.61M | 270.6M | 640.9M | 429.55M | 246.02M |
Interest Expense | 2.54M | 3.03M | n/a | 3.21M | 2.84M | 2.47M |
Selling & Marketing Expenses | 88.41M | 67.37M | 60.96M | 122.08M | 112.74M | 63.18M |
Cost & Expenses | 439.34M | 328.66M | 383.16M | 902.35M | 658.34M | 421.32M |
Income Tax Expense | -116K | -343K | -926K | -49.05M | n/a | n/a |
Shares Outstanding (Basic) | 26.89M | 26.89M | 24.31M | 10.24M | 3.28M | 5.63M |
Shares Outstanding (Diluted) | 26.89M | 26.89M | 24.31M | 10.24M | 3.28M | 5.63M |
EPS (Basic) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 | -33.16 |
EPS (Diluted) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 | -146.94 |
EBITDA | 6.63M | -27.64M | -136.46M | -398.2M | -220.75M | -227.13M |
EBIT | -18.6M | -49.6M | -170.19M | -457.51M | -242.56M | -238.87M |
Depreciation & Amortization | 25.22M | 21.95M | 33.73M | 59.31M | 21.81M | 11.73M |
Add to Watchlist
Select watchlists to add or remove WGS